Fig. 3

Direct immunofluorescence (DIF) of BHK-21 cell monolayer after treatment with RABV and different molecules. a F11 (1.0 mg.mL⁻¹); b synthetic OF1 (1.0 mg.mL⁻¹); c OF1TP (6.0 mg.mL⁻¹); d bufotenine (0.8 mg.mL⁻¹); e bufotenine (0.8 mg.mL⁻¹) and F11 (1.0 mg.mL⁻¹); f bufotenine (0.8 mg.mL⁻¹) and synthetic OF1 (1.0 mg.mL⁻¹); g bufotenine (0.8 mg.mL⁻¹) and OF1TP (6.0 mg.mL⁻¹); h negative control (MEM-FBS only) and i positive control (PV only). Magnification 200×